Healthcare Sales & Marketing Network News: Diabetes Care

Searching News Database: Diabetes Care

HSMN NewsFeed - 16 Jul 2026
Lilly to Acquire AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Apr 2026
Lilly to Acquire Ajax Therapeutics to Advance Outcomes for Patients with Myelofibrosis and Polycythemia Vera
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 13 Apr 2026
Lilly's Jaypirca (Pirtobrutinib) Significantly Extended Progression-Free Survival When Added to a Venetoclax Time-Limited Regimen in Patients with Previously Treated CLL/SLL
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Mar 2026
Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Feb 2026
Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Oct 2025
ViCentra Strengthens Leadership Team to Accelerate Growth
Devices Endocrinology Drug Delivery Personnel

HSMN NewsFeed - 29 Sep 2025
Novo Nordisk Resubmits Awiqli(R) to the FDA With Potential to be the First Once-Weekly Basal Insulin Treatment for Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 16 Sep 2025
Roche Receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App Integration, Offering an Enhanced Diabetes Management Experience
Devices Monitoring Regulatory

HSMN NewsFeed - 20 Aug 2025
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 12 Jun 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
Devices Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 8 May 2025
Lilly Announces Transitions in Executive Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Feb 2025
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2025
Most Patients on Lilly's Omvoh(R) (mirikizumab-mrkz) for Crohn's Disease Achieved Sustained Clinical Remission and Endoscopic Response at Two Years
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 3 Dec 2024
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Devices Interventional Product Launch

HSMN NewsFeed - 25 Oct 2024
Lilly's EBGLYSS(TM) (lebrikizumab-lbkz) Demonstrated Meaningful Improvement in Skin Clearance and Itch Relief in the Majority of Patients with Moderate-To-Severe Atopic Dermatitis Who Discontinued Dupilumab
Biopharmaceuticals Dermatology

HSMN NewsFeed - 4 Oct 2024
Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life
Devices Drug Delivery Product Recall

HSMN NewsFeed - 9 Sep 2024
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Aug 2024
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 5 Jun 2024
Lilly announces departure of Anat Ashkenazi, chief financial officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 May 2024
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
Devices Monitoring FDA

HSMN NewsFeed - 8 Mar 2024
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 27 Dec 2023
Lilly Completes Acquisition of POINT Biopharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Sep 2023
Abbott Completes Acquisition of Bigfoot Biomedical
Devices Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 29 Jun 2023
Lilly to Acquire Sigilon Therapeutics
Biopharmaceuticals Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 20 Jun 2023
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Apr 2023
Lilly to Divest BAQSIMI to Amphastar
Biopharmaceuticals Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Devices Neurology FDA

HSMN NewsFeed - 15 Nov 2022
Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
Devices Endocrinology Product Launch

HSMN NewsFeed - 29 Sep 2022
MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
Devices Wound Care Group Purchasing

HSMN NewsFeed - 5 Jul 2022
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy
Devices Neurology

HSMN NewsFeed - 7 Jun 2022
Eight out of Ten Patients Maintained Skin Clearance at One Year in Lilly's Lebrikizumab Atopic Dermatitis Monotherapy Trials
Biopharmaceuticals Dermatology

HSMN NewsFeed - 31 May 2022
Abbott's FreeStyle Libre(R) 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 24 May 2022
Fifty Percent of Patients with Ulcerative Colitis Treated with Mirikizumab Achieved Clinical Remission at One Year in Lilly's Pivotal Phase 3 Study
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 24 Mar 2022
Abbott's FreeStyle(R) Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin
Devices Monitoring Reimbursement

HSMN NewsFeed - 22 Feb 2022
MicroVention Announces First U.S. Patient Treated with FRED(TM) X(TM) Flow Diverter Featuring X Technology
Devices Interventional Neurosurgery

HSMN NewsFeed - 5 Aug 2021
Christopher Reidy Announces Intent to Retire from BD
Devices Personnel

HSMN NewsFeed - 2 Aug 2021
Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 14 Jul 2021
Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
Devices Interventional Product Launch

HSMN NewsFeed - 12 Jul 2021
BD Announces Two Future Directors for Diabetes Care Spinoff Company
Devices Endocrinology Personnel

HSMN NewsFeed - 26 May 2021
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
Devices Drug Delivery Endocrinology Regulatory

HSMN NewsFeed - 19 May 2021
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
Devices Endocrinology Product Launch

HSMN NewsFeed - 6 May 2021
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 6 May 2021
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Devices Endocrinology Acquisitions

HSMN NewsFeed - 14 Apr 2021
Medtronic Announces European Launch of World's First Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes
Devices Drug Delivery Product Launch

HSMN NewsFeed - 25 Feb 2021
Welldoc and Lilly collaborate to integrate BlueStar(R) app capabilities into Lilly's connected insulin solutions
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 12 Jan 2021
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
Devices Neurosurgery FDA

HSMN NewsFeed - 5 Jan 2021
Terumo Enters 100th Anniversary Year
Devices

HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 19 Nov 2020
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
Devices Drug Delivery Endocrinology

HSMN NewsFeed - 12 Nov 2020
Medtronic Launches InPen(TM) with Real-Time Guardian(TM) Connect CGM Data -- the First Integrated Smart Insulin Pen for People with Diabetes on MDI
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 1 Sep 2020
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
Devices Monitoring Endocrinology Reimbursement

HSMN NewsFeed - 30 Jul 2020
Jardiance(R) meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 24 Mar 2020
Updates from Lilly about Insulin Supply and Affordability
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Feb 2020
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Devices Monitoring Drug Delivery Endocrinology

HSMN NewsFeed - 30 Jan 2020
Oramed Appoints Dr. Julio Rosenstock to Its Scientific Advisory Board
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 16 Dec 2019
Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Devices Drug Delivery Monitoring Endocrinology

HSMN NewsFeed - 13 Nov 2019
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
Devices Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2019
Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to Retire at End of Year; Mike Mason to Succeed Conterno
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory

HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Devices Monitoring Endocrinology Reimbursement

HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 8 Apr 2019
LifeScan Names Brian Heald as its New Head of Product
Devices Diagnostics Personnel

HSMN NewsFeed - 4 Mar 2019
Lilly to Introduce Lower-Priced Insulin
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 14 Feb 2019
Boehringer Ingelheim and Lilly announce the CAROLINA(R) cardiovascular outcome trial of Tradjenta(R) met its primary endpoint of non-inferiority compared with glimepiride
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 25 Jan 2019
Companion Medical Announces Launch of the InPen(TM) System for Android
Devices Drug Delivery Product Launch

HSMN NewsFeed - 24 Jan 2019
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
Devices Drug Delivery FDA Product Launch

HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 15 Oct 2018
Abbott Names Robert B. Ford President, Chief Operating Officer
Diagnostics Devices Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2018
Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 2 Oct 2018
Results from Two Phase 3 Studies Show Lilly's Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 25 Sep 2018
CONTOUR(R)NEXT Blood Glucose Monitoring System Tops the List in Recently Published Independent Accuracy Assessment by Diabetes Technology Society
Devices Monitoring Endocrinology

HSMN NewsFeed - 9 Jul 2018
Companion Medical Announces FDA Clearance for the InPen System for Android
Devices Endocrinology FDA

HSMN NewsFeed - 31 May 2018
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
Diagnostics Endocrinology Product Launch

HSMN NewsFeed - 25 Apr 2018
Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 4 Apr 2018
Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 12 Mar 2018
Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 8 Mar 2018
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 26 Feb 2018
New Data Show Lilly's Trulicity(R) (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 21 Feb 2018
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
Devices Drug Delivery Product Launch

HSMN NewsFeed - 14 Feb 2018
Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 8 Feb 2018
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
Biopharmaceuticals Product Launch

HSMN NewsFeed - 7 Feb 2018
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 28 Dec 2017
Integrity Applications Signs Distribution Agreement for Its GlucoTrack(R) Non-Invasive Glucose Monitoring Device in the Netherlands
Devices Endocrinology Distribution

HSMN NewsFeed - 14 Dec 2017
Companion Medical Announces U.S. Commercial Launch of Smart Insulin Pen System
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 5 Oct 2017
Animas Corporation to Close Operations and Exit Insulin Pump Market
Devices Endocrinology

HSMN NewsFeed - 31 Aug 2017
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabalin in Diabetic Peripheral Neuropathic Pain
Biopharmaceuticals

HSMN NewsFeed - 3 Aug 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Biopharmaceuticals Wound Care

HSMN NewsFeed - 9 Jun 2017
IDF, in partnership with Lilly, announces second phase of BRIDGES programme funding for translational research in diabetes with focus on secondary prevention
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 8 May 2017
Abbott Announces National Reimbursement for FreeStyle(R) Libre in France, Providing Access to Revolutionary Technology for People with Diabetes
Diagnostics Endocrinology Reimbursement

HSMN NewsFeed - 5 Apr 2017
MicroPort Orthopedics Inc. Announces Launch of its EVOLUTION(R) Revision Tibial System and EVOLUTION(R) BioFoam(R) Tibia
Devices Orthopaedic Product Launch

HSMN NewsFeed - 15 Feb 2017
Aqua Pharmaceuticals Bolsters Executive Team With Three New Hires
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 20 Oct 2016
Medtronic Announces Health Canada Licence of the MiniMed(TM) 630G System with New User-Friendly Insulin Pump Design and SmartGuard(TM) Technology
Devices Drug Delivery Endocrinology Regulatory

HSMN NewsFeed - 28 Sep 2016
Abbott Receives FDA Approval for the FreeStyle Libre Pro(TM) System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 21 Sep 2016
U.S. FDA Approves INVOKAMET(R) XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 20 Sep 2016
KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Sep 2016
Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 26 Apr 2016
Intuity Medical Receives FDA Clearance to Market POGO(R) Automatic(TM) Blood Glucose Monitoring System
Diagnostics Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 17 Feb 2016
New OneTouch Verio Flex(TM) Blood Glucose Meter Takes the Guesswork Out of Blood Sugar Test Results
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 16 Feb 2016
Abbott Receives Approval in Australia for FreeStyle(R) Libre--the Revolutionary Glucose Monitoring System for People with Diabetes
Devices Endocrinology Monitoring Regulatory

HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 19 Jan 2016
Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace
Devices Personnel

HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 4 Dec 2015
Lilly Ends Basal Insulin Peglispro Development Program
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Nov 2015
Akers Biosciences Appoints Medical Technology Specialist as CEO
Diagnostics Personnel

HSMN NewsFeed - 8 Sep 2015
Vanda Pharmaceuticals Announces the Appointment of European General Manager
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Sep 2015
SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 1 Sep 2015
CeQur Announces $100 Million Series C Financing
Devices Drug Delivery Endocrinology Venture Capital

HSMN NewsFeed - 25 Aug 2015
FDA Approves Dexcom G5(R) Mobile Continuous Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 20 Aug 2015
Jardiance(R) Demonstrated Cardiovascular (CV) Risk Reduction in People with Type 2 Diabetes at High Risk for CV Events
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Jun 2015
Panasonic Healthcare and Bayer Diabetes Care to Create Leading Global Diabetes Care Solutions Business
Biopharmaceuticals Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 28 May 2015
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
Devices Venture Capital Personnel

HSMN NewsFeed - 18 Aug 2014
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 6 Aug 2014
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 5 Aug 2014
Boston Therapeutics Expands Medical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2014
Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Jun 2014
Senseonics Raises $20 Million
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 1 May 2014
EndoGastric Solutions Names Industry Veteran Skip Baldino CEO
Devices Personnel

HSMN NewsFeed - 10 Apr 2014
CeQur(R) Appoints Douglas Lawrence Chief Executive Officer
Devices Endocrinology Personnel

HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 25 Feb 2014
Boston Therapeutics Appoints Larry K. Ellingson, Former Chair of the American Diabetes Association, as Chair of Its Scientific Advisory Board
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 30 Jan 2014
Novo Nordisk Promotes Eddie Williams to Senior Vice President
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel

HSMN NewsFeed - 9 Jan 2014
MicroPort Scientific Corporation and Sorin Group Sign Joint Venture Agreement for Cardiac Rhythm Management Business in China
Devices Cardiology

HSMN NewsFeed - 12 Nov 2013
Bayer receives approval for Eylea(R) as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 17 Oct 2013
Health Canada Approves A New Treatment Option For Patients With Gastrointestinal Stromal Tumours (GIST), A Rare Form Of Sarcoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Sep 2013
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
Devices Diagnostics Monitoring Regulatory

HSMN NewsFeed - 23 Aug 2013
Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field from Abbott
Devices Endocrinology Monitoring Licensing

HSMN NewsFeed - 21 Aug 2013
Novo Nordisk receives U.S. FDA clearance for the insulin injection device NovoPen Echo(R)
Biopharmaceuticals Devices Drug Delivery FDA

HSMN NewsFeed - 25 Jul 2013
Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System(TM)
Devices Endocrinology Monitoring FDA

HSMN NewsFeed - 29 Apr 2013
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 15 Apr 2013
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx(R) Blood Glucose Meters in the United States
Devices Monitoring Endocrinology Product Recall

HSMN NewsFeed - 4 Feb 2013
Graftjacket(R) Regenerative Tissue Matrix Receives Medicare Reimbursement in Ten Northwestern States
Devices Wound Care Reimbursement

HSMN NewsFeed - 2 Jan 2013
Abbott Completes Separation of Research-Based Pharmaceuticals Business
Biopharmaceuticals

HSMN NewsFeed - 1 Oct 2012
Roche Diagnostics ACCU-CHEK Combo Insulin Pump System Now Available in United States
Devices Monitoring Drug Delivery Endocrinology

HSMN NewsFeed - 5 Sep 2012
DERMAGRAFT(R) Approved in Canada for Treatment of Diabetic Foot Ulcers
Devices Wound Care Regulatory

HSMN NewsFeed - 2 Jul 2012
Mike Mathews Named Senior Vice President, International at KCI
Devices Wound Care Personnel

HSMN NewsFeed - 30 May 2012
Echo Therapeutics Hires Marketing Executive
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 22 May 2012
FDA Approves Levemir(R) for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 8 May 2012
SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE
Devices Wound Care FDA

HSMN NewsFeed - 27 Apr 2012
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2012
FDA Approves Levemir(R) Pregnancy Category Change for Women with Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 23 Mar 2012
BYETTA(R) Approved for Use with Basal Insulin in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 29 Feb 2012
Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
Devices Endocrinology Drug Delivery Monitoring

HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2012
Alan Raffensperger appointed Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2012
Digirad Names Sarah L. Hanssen Senior Vice President of Strategic Marketing and Business Development
Diagnostics Personnel

HSMN NewsFeed - 29 Nov 2011
SweetSpot Diabetes Care Receives FDA 510(k) Clearance for SweetSpot Diabetes Data Management Service
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 16 Nov 2011
Alphatec Spine Appoints New Senior Vice President, Global Marketing and Asia Pacific
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 8 Nov 2011
Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2011
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
Devices Wound Care

HSMN NewsFeed - 26 Oct 2011
Phase III Trial of Bayer's Investigational Compound Regorafenib (BAY 73-4506) in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Oct 2011
Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
Biopharmaceuticals Devices Diagnostics

HSMN NewsFeed - 23 Aug 2011
FDA Grants Fast Track Designation to Bayer's Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Aug 2011
Echo Therapeutics Hires Seasoned Diabetes Management Executive
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 21 Jun 2011
Bydureon Receives Marketing Authorization in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 6 Jun 2011
Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 May 2011
Asante Solutions Receives FDA Clearance for Pearl Insulin Pump
Devices Endocrinology FDA

HSMN NewsFeed - 9 May 2011
Medtronic and Bayer HealthCare Expand International Alliance
Devices Endocrinology

HSMN NewsFeed - 21 Apr 2011
Novo Nordisk Announces U.S. Launch of NovoTwist(R) for Use with Levemir(R) FlexPen(R), NovoLog(R) FlexPen(R) and Victoza(R) Pen Devices
Devices Drug Delivery Endocrinology

HSMN NewsFeed - 15 Apr 2011
BYDUREON Recommended for Approval in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 11 Apr 2011
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
Devices Monitoring Endocrinology

HSMN NewsFeed - 25 Mar 2011
Second Lucentis Phase III Study Meets Primary Endpoint for Improved Vision in Patients with Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 15 Mar 2011
U.S. FDA Approves Bayer's Gadavist (Gadobutrol) Injection for MRI of the Central Nervous System
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 24 Feb 2011
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Feb 2011
FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Jan 2011
Lilly and Boehringer Ingelheim Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Jan 2011
Insulet Appoints Charles Liamos as Chief Operating Officer
Devices Endocrinology Personnel

HSMN NewsFeed - 8 Jan 2011
Important Information for Betaseron (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products
Biopharmaceuticals Devices Product Recall

HSMN NewsFeed - 23 Aug 2010
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem(R) 10 mcg
Biopharmaceuticals

HSMN NewsFeed - 29 Jul 2010
Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 27 Jul 2010
Titan Medical Inc. Announces MOU with Rochester General Hospital
Devices Surgery

HSMN NewsFeed - 29 Jun 2010
New Lancing System Delivers More Comfortable Blood Glucose Testing(1)
Devices Endocrinology

HSMN NewsFeed - 28 Jun 2010
Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
Biopharmaceuticals

HSMN NewsFeed - 25 Jun 2010
Medtronic Begins Enrollment in ASPIRE Pivotal Study of Low Glucose Suspend Integrated System
Devices Endocrinology

HSMN NewsFeed - 14 Jun 2010
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jun 2010
BD Launches World's Smallest Pen Needle
Devices Drug Delivery Endocrinology

HSMN NewsFeed - 4 Jun 2010
Bayer Presents Clinical Data on Alpharadin in Metastatic Castration-Resistant Prostate Cancer (CRPC)
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 May 2010
Organogenesis Announces Symposium for the Treatment of Chronic Wounds at EWMA Annual Conference in Switzerland
Regenerative Medicine Wound Care

HSMN NewsFeed - 7 May 2010
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Mar 2010
Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management
Devices Endocrinology FDA

HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Biopharmaceuticals

HSMN NewsFeed - 11 Mar 2010
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 3 Mar 2010
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Biopharmaceuticals Devices Drug Delivery FDA

HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 29 Dec 2009
American Diabetes Association's New Clinical Practice Recommendations Promote A1C as Diagnostic Test for Diabetes
Diagnostics Endocrinology

HSMN NewsFeed - 15 Dec 2009
Ultroid(R) Technologies, Inc. Appoints New CEO
Devices Personnel

HSMN NewsFeed - 30 Nov 2009
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology

HSMN NewsFeed - 27 Nov 2009
Diabetes Prevalence Expected to Double in Next 25 Years
Endocrinology Wound Care

HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Sep 2009
Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Sep 2009
Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 22 Sep 2009
Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Sep 2009
Lilly Names New Business Leaders
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Aug 2009
Insulet Appoints Peter J. Devlin as Chief Commercial Officer
Devices Endocrinology Personnel

HSMN NewsFeed - 22 Jul 2009
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Jul 2009
FDA Approves NovoLog(R) Labeling Update
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 17 Jun 2009
Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
Devices Monitoring Licensing Endocrinology

HSMN NewsFeed - 9 Jun 2009
Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 1 Jun 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 May 2009
Novo Nordisk: New study directly comparing insulin delivery devices shows that Next Generation FlexPen has a significantly lower injection force than SoloStar and KwikPen
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 20 May 2009
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 12 May 2009
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Biopharmaceuticals Diagnostics Monitoring Endocrinology

HSMN NewsFeed - 11 May 2009
Medtronic Announces San Antonio as Home of New Diabetes Facility
Devices Endocrinology

HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 30 Apr 2009
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 29 Apr 2009
New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Apr 2009
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 24 Mar 2009
American Medical Systems Announces New General Manager of BPH Therapy Business
Devices Personnel

HSMN NewsFeed - 23 Mar 2009
ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
Devices Personnel

HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Mar 2009
KCI Introduces new V.A.C.(R) GranuFoam(TM) Bridge Dressing
Devices Wound Care

HSMN NewsFeed - 26 Jan 2009
Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2009
Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
Biopharmaceuticals

HSMN NewsFeed - 6 Jan 2009
MEDRAD Sponsors PET Research with University of Zurich
Devices Drug Delivery Radiology Oncology

HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 10 Oct 2008
FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Oct 2008
KCI Names New General Manager
Devices Wound Care Personnel

HSMN NewsFeed - 8 Oct 2008
Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 15 Sep 2008
Betaseron(R) to Offer the Thinnest Needle in Multiple Sclerosis
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 9 Sep 2008
Mom with Diabetes Invents Device to Make Insulin Injections Easier
Devices Drug Delivery Endocrinology

HSMN NewsFeed - 8 Sep 2008
Major Study Reinforces the Power of Medtronic Device for Better Diabetes Management
Devices Endocrinology

HSMN NewsFeed - 28 Aug 2008
ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Aug 2008
Confirma and MEDRAD Partner to Advance Patient Care in the European Union
Devices Radiology

HSMN NewsFeed - 18 Aug 2008
Bausch & Lomb Names Presidents for Europe, Middle East, & Africa and Asia Pacific Regions
Devices Ophthalmology Personnel

HSMN NewsFeed - 11 Aug 2008
MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System
Devices FDA

HSMN NewsFeed - 30 Jul 2008
Oscient Pharmaceuticals Promotes Mark A. Glickman to Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2008
Nexavar Approved for Liver Cancer in China
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 2 Jul 2008
Bayer HealthCare and Maxygen Announce Hematology Agreement
Biopharmaceuticals Licensing Acquisitions

HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 17 Jun 2008
MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
Devices Radiology FDA

HSMN NewsFeed - 17 Jun 2008
The Medicines Company Hires Glyn R. Parkin as Senior Vice President, International Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2008
Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Diagnostics Cardiology

HSMN NewsFeed - 27 May 2008
ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
Biopharmaceuticals FDA

HSMN NewsFeed - 19 May 2008
Bayer Announces Availability of Reformulated Liquid Leukine(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 May 2008
Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 16 May 2008
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 May 2008
FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2008
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 1 May 2008
Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2008
ZymoGenetics Presents Positive Results from RECOTHROM(TM) Thrombin, topical (Recombinant) Spray Study in Burn Patients
Biopharmaceuticals Wound Care

HSMN NewsFeed - 22 Apr 2008
Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System
Devices Endocrinology Distribution

HSMN NewsFeed - 14 Apr 2008
Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
Devices Endocrinology

HSMN NewsFeed - 27 Mar 2008
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Mar 2008
Medtronic Announces Sales Milestone of One Million Continuous Glucose Monitoring Sensors Worldwide
Devices Endocrinology Monitoring

HSMN NewsFeed - 13 Mar 2008
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Mar 2008
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
Devices FDA Endocrinology

HSMN NewsFeed - 11 Mar 2008
Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
Biopharmaceuticals Devices Radiology

HSMN NewsFeed - 7 Mar 2008
Lilly Announces Termination of AIR Insulin Program
Biopharmaceuticals Endocrinology Drug Delivery

HSMN NewsFeed - 4 Mar 2008
MEDRAD(R) Revenues Grow 10 Percent in 2007
Devices Radiology

HSMN NewsFeed - 4 Mar 2008
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Feb 2008
Deal between Freedom Meditech and Battelle Could Lead to Breakthrough in Diabetes Management
Devices Endocrinology

HSMN NewsFeed - 21 Feb 2008
Lilly Launches KwikPen(TM) for Humalog(R) and Humalog Mixtures
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 19 Feb 2008
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2008
Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Feb 2008
Final Study Results Show V.A.C.(R) Therapy to be More Efficacious Than Advanced Moist Wound Therapy in Treating Diabetic Foot Ulcers
Devices Wound Care

HSMN NewsFeed - 11 Feb 2008
Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
Devices Mergers & Acquisitions

HSMN NewsFeed - 21 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 19 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 17 Jan 2008
FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical (Recombinant)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jan 2008
Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 19 Dec 2007
Ex-Hypoguard CEO to Lead WaveSense(TM) Sales and Marketing
Devices Personnel

HSMN NewsFeed - 6 Dec 2007
Pelikan Technologies Closes $69 Million Series F Financing and Secures a Further $20 Million in Debt Financing
Devices Venture Capital

HSMN NewsFeed - 6 Dec 2007
Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 20 Nov 2007
MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
Devices Radiology

HSMN NewsFeed - 20 Nov 2007
Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Biopharmaceuticals Radiology Group Purchasing

HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Nov 2007
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Nov 2007
Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology

HSMN NewsFeed - 14 Nov 2007
NeuroMetrix Announces Strategic Alliance with Cyberkinetics
Devices Neurology

HSMN NewsFeed - 8 Nov 2007
Bayer HealthCare Pharmaceuticals, HealthTrust Purchasing Group Sign a Three-Year Renewal Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Biopharmaceuticals Radiology Group Purchasing

HSMN NewsFeed - 7 Nov 2007
BRIGHT Results Show Less Pain and Higher Patient Satisfaction with Betaseron(R) than with Rebif(R)
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Nov 2007
Bayer Temporarily Suspends Global Trasylol(R) Marketing
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
Devices Personnel

HSMN NewsFeed - 30 Oct 2007
Nexavar Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Oct 2007
MicroCHIPS Hires Industry Veteran Robert Farra to Lead Diabetes and Drug Delivery Product Programs
Devices Personnel

HSMN NewsFeed - 18 Oct 2007
Lilly and MacroGenics Announce Licensing and Collaboration Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Sep 2007
VeraLight Names Mirasol Panlilio VP Marketing and Sales
Devices Endocrinology Personnel

HSMN NewsFeed - 21 Sep 2007
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Sep 2007
Digital Healthcare Wins FDA Approval for Retasure
Devices Ophthalmology FDA

HSMN NewsFeed - 18 Sep 2007
MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
Devices Radiology

HSMN NewsFeed - 30 Aug 2007
MEDRAD Introduces New Pressure-Rated Disposable for CT Power Injection
Devices

HSMN NewsFeed - 28 Aug 2007
Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
Biopharmaceuticals Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 23 Aug 2007
Oscient Pharmaceuticals Names Aaron D. Berg Vice President of Marketing and Mark A. Glickman Vice President of Sales
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Aug 2007
Medtronic and Bayer Diabetes Care Announce Alliance to Provide Blood Glucose Meter to Medtronic Patients Outside the United States
Devices Monitoring Endocrinology

HSMN NewsFeed - 20 Aug 2007
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 6 Aug 2007
Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 3 Aug 2007
Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 23 Jul 2007
MEDRAD(R) Announces New Head of Corporate Services
Devices Radiology Personnel

HSMN NewsFeed - 23 Jul 2007
MEDRAD(R) Announces New Head of Magnetic Resonance Business Unit
Devices Radiology Personnel

HSMN NewsFeed - 23 Jul 2007
Premier Extends Agreement With Bayer HealthCare Pharmaceuticals
Biopharmaceuticals Radiology Group Purchasing

HSMN NewsFeed - 16 Jul 2007
Premier Awards MEDRAD Two-Year Contract Extension for Vascular Injection Systems
Devices Radiology Group Purchasing

HSMN NewsFeed - 10 Jul 2007
MEDRAD Introduces New Extravasation Detector Technology
Devices Radiology

HSMN NewsFeed - 29 Jun 2007
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
Biopharmaceuticals

HSMN NewsFeed - 27 Jun 2007
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Jun 2007
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir(R)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 24 Jun 2007
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
New Study Demonstrates Colesevelam HCl Lowers Both A1C and LDL Cholesterol in Patients With Uncontrolled Type 2 Diabetes Mellitus on Metformin-Based Regimen
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
Results of Two Head-to-Head Studies Demonstrated Long-Acting Insulin Lantus(R) Lowered Free Fatty Acid Levels Equal to or Better Than Thiazolidinediones
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Jun 2007
Bayer and Onyx Submit New European Marketing Authorization Application to EMEA for Nexavar to Treat Liver Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 19 Jun 2007
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Jun 2007
Abbott Receives European CE Mark Approval for FreeStyle Navigator(R) Continuous Glucose Monitoring System
Devices Monitoring Endocrinology Regulatory

HSMN NewsFeed - 4 Jun 2007
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 21 May 2007
Milestone Scientific Forms New Medical Division and Appoints Former Bayer Senior Executive as Its CEO
Devices Drug Delivery Personnel

HSMN NewsFeed - 7 May 2007
Bayer HealthCare and Intendis Announce Strategic Alliance to Co-Promote Yaz(R) (Drospirenone/Ethinyl Estradiol) for Treatment of Moderate Acne
Biopharmaceuticals Dermatology

HSMN NewsFeed - 3 May 2007
Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron(R)
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 May 2007
First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron(R) Significantly Delayed Permanent Disability
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Apr 2007
FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes
Biopharmaceuticals Endocrinology Drug Delivery FDA

HSMN NewsFeed - 16 Apr 2007
Abbott Announces FDA Clearance and Launch of New FreeStyle Lite(TM) Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 4 Apr 2007
Bayer Healthcare Pharmaceuticals Officially Launches in the United States
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Mar 2007
Introducing New ALEVE(R) Liquid Gels
Biopharmaceuticals

HSMN NewsFeed - 12 Mar 2007
Novo Nordisk Appoints Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2007
Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
Biopharmacetuicals

HSMN NewsFeed - 1 Mar 2007
Study Confirms That Significant Insulin Dose Errors Can Result When Blood Glucose Meters are Miscoded
Devices Monitoring Endocrinology

HSMN NewsFeed - 22 Feb 2007
Lilly Introduces World's First Digital Insulin Pen With Memory
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 20 Feb 2007
New Storage Instructions Approved for BYETTA(R)
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 12 Feb 2007
Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Feb 2007
Roche Continues to Strengthen Research and Development
Biopharmaceuticals

HSMN NewsFeed - 29 Jan 2007
FDA Approves New Indication for YAZ(R) to Treat Acne
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 25 Jan 2007
Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
Biopharmaceuticals

HSMN NewsFeed - 18 Jan 2007
Abbott To Sell Its Core Laboratory Diagnostics Business, Including Point Of Care, To GE For $8.13 Billion
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Jan 2007
Bayer and Onyx Announce Pivotal Nexavar(R) Kidney Cancer Study Published in New England Journal of Medicine
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jan 2007
Novo Nordisk Appoints Nathaniel Clark, M.D., as Senior Medical Advisor - Diabetes
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 5 Jan 2007
OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 5 Jan 2007
Lilly and OSI Pharmaceuticals Announce Licensing Agreement
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 3 Jan 2007
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 2 Jan 2007
Daiichi Sankyo, Inc. Announces Filing of Supplemental New Drug Application for WelChol in the Treatment of Type 2 Diabetes Mellitus
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 22 Dec 2006
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 15 Dec 2006
Abbott Completes Acquisition of Kos Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Dec 2006
Novo Nordisk to Pursue Lawsuit Despite Preliminary Injunction Denial
Biopharmaceuticals Litigation

HSMN NewsFeed - 6 Dec 2006
New Evidence Reinforces Efficacy and Tolerability of Galvus(R) as a New Once-Daily Oral Treatment Option for Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 5 Dec 2006
New Data Shows Rimonabant Benefited Patients with Type 2 Diabetes by Improving Blood Sugar Control, Reducing Weight and Acting on Other Cardiometabolic Risk Factors
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 4 Dec 2006
Phase III Trial of Nexavar in Patients with Advanced Melanoma Does Not Meet Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Nov 2006
Cardiocom(TM) Announces New GlucoCom(TM) Division and Diabetes Product Sales Team
Devices Personnel

HSMN NewsFeed - 21 Nov 2006
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 15 Nov 2006
New Study Confirms WelChol Improves Glycemic Control in Patients With Uncontrolled Type 2 Diabetes Mellitus on Insulin
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 6 Nov 2006
Significant Errors In Insulin Dose Can Result When Blood Glucose Meters Are Miscoded According to New Clinical Study
Devices Diagnostics Monitoring Endocrinology

HSMN NewsFeed - 25 Oct 2006
NeuroMetrix, Inc. Signs Exclusive Licensing Agreement with EyeTel Imaging, Inc. for the Detection of Diabetic Retinopathy
Devices Ophthalmology Licensing

HSMN NewsFeed - 18 Oct 2006
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 17 Oct 2006
NovoSeven(R) Becomes First and Only Recombinant Therapy for Treatment of Rare, Life-Threatening Bleeding Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Oct 2006
Novartis Launches 'GALIANT' Study Comparing the Investigational Drug Galvus(R) and a Leading Class of Oral Anti-Diabetic Medicines
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 2 Oct 2006
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
Diagnostics Endocrinology

HSMN NewsFeed - 29 Sep 2006
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
Devices Diagnostics Endocrinology

HSMN NewsFeed - 29 Sep 2006
Study Shows Non-Invasive Device Outperforms Fasting Plasma Glucose and A1C for Diabetes Screening
Devices Endocrinology

HSMN NewsFeed - 28 Sep 2006
BD Announces Plan to Exit Blood Glucose Monitoring Market
Devices Monitoring

HSMN NewsFeed - 27 Sep 2006
Cubist Pharmaceuticals Appoints Martin Soeters to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2006
Exenatide Receives Positive Opinion From the European Committee for Medicinal Products for Human Use for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Sep 2006
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 13 Sep 2006
One in Three Parents Surveyed Unaware of Easy Ketone Test That May Help Prevent the Onset of Diabetic Ketoacidosis (DKA)
Diagnostics Endocrinology

HSMN NewsFeed - 7 Sep 2006
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Biopharmaceuticals

HSMN NewsFeed - 23 Jul 2006
Nexavar(R) Approved by European Commission for the Treatment of Advanced Kidney Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Jul 2006
Bayer HealthCare Introduces Free Product Trial Program For Kogenate(R) FS with BIO-SET(R)
Biopharmaceuticals

HSMN NewsFeed - 6 Jul 2006
Bayer Acquires Metrika Inc.
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 27 Jun 2006
Novo Nordisk Prevails in sanofi-aventis Challenge to Levemir(R) - Up to 24 Hours Duration of Action and Other Claims Upheld
Biopharmaceuticals Litigation

HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Devices Ophthalmology Licensing

HSMN NewsFeed - 15 May 2006
Novo Nordisk Announces New Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2006
Novo Nordisk Appoints Edward Williams as Vice President of Biopharmaceuticals
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 182

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 182 additional stories matching:
Diabetes Care
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!